Search Results - "Labelle, Caroline"

Genetic characterization of ABT-199 sensitivity in human AML by Bisaillon, Richard, Moison, Céline, Thiollier, Clarisse, Krosl, Jana, Bordeleau, Marie-Eve, Lehnertz, Bernhard, Lavallée, Vincent-Philippe, MacRae, Tara, Mayotte, Nadine, Labelle, Caroline, Boucher, Geneviève, Spinella, Jean-François, Boivin, Isabel, D’Angelo, Giovanni, Lavallée, Sylvie, Marinier, Anne, Lemieux, Sébastien, Hébert, Josée, Sauvageau, Guy

“…Acute myeloid leukemias (AML) with mutations in the NPM1 gene (NPM1c+) represent a large AML subgroup with varying response to conventional treatment,…”
Get full text

Enhancing the drug discovery process: Bayesian inference for the analysis and comparison of dose–response experiments by Labelle, Caroline, Marinier, Anne, Lemieux, Sébastien

“…Abstract Motivation The efficacy of a chemical compound is often tested through dose–response experiments from which efficacy metrics, such as the IC50, can be…”
Get full text

Genetic Characterization of ABT-199 Sensitivity in Human AML by Bordeleau, Marie-Eve, Bisaillon, Richard, Thiollier, Clarisse, Krosl, Jana, Lehnertz, Bernhard, Lavallee, Vincent-Philippe, MacRae, Tara, Caroline, Labelle, Boucher, Geneviève, Boivin, Isabel, D'Angelo, Giovanni, Lavallée, Sylvie, Marinier, Anne, Lemieux, Sébastien, Hébert, Josée, Sauvageau, Guy

“…Acute myeloid leukemias (AML) are aggressive blood cancers characterized by an overall survival of 27% at 5 years. The main challenge in AML treatment…”
Get full text